View ValuationBeit Jala Pharmaceutical 将来の成長Future 基準チェック /06現在、 Beit Jala Pharmaceuticalの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Pharmaceuticals 収益成長16.1%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Jul 16Beit Jala Pharmaceutical Company to Report First Half, 2026 Results on Jul 29, 2026Beit Jala Pharmaceutical Company announced that they will report first half, 2026 results on Jul 29, 2026お知らせ • May 03Beit Jala Pharmaceutical Company Announces Distribution of Cash DividendsBeit Jala Pharmaceutical Company at the ordinary General Assembly, held on April 30, 2026, announced the distribution of cash dividends of 15% of the nominal value of the share.お知らせ • Apr 10Beit Jala Pharmaceutical Company, Annual General Meeting, Apr 30, 2026Beit Jala Pharmaceutical Company, Annual General Meeting, Apr 30, 2026. Location: nablus Palestinian Authorityお知らせ • Mar 30+ 1 more updateBeit Jala Pharmaceutical Company to Report Second Half, 2025 Results on Apr 07, 2026Beit Jala Pharmaceutical Company announced that they will report second half, 2025 results on Apr 07, 2026お知らせ • Dec 10Beit Jala Pharmaceutical Company to Report Nine Months, 2025 Results on Dec 18, 2025Beit Jala Pharmaceutical Company announced that they will report nine months, 2025 results on Dec 18, 2025お知らせ • May 03Beit Jala Pharmaceutical Company announces Annual dividend, payable on June 30, 2025Beit Jala Pharmaceutical Company announced Annual dividend of JOD 0.1200 per share payable on June 30, 2025, ex-date on May 04, 2025 and record date on May 05, 2025.お知らせ • Apr 11Beit Jala Pharmaceutical Company, Annual General Meeting, Apr 30, 2025Beit Jala Pharmaceutical Company, Annual General Meeting, Apr 30, 2025. Location: ramallah Palestinian AuthorityBoard Change • Oct 03No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. No independent directors (9 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • Sep 03Second quarter 2024 earnings released: EPS: د.أ0.047 (vs د.أ0.11 in 2Q 2023)Second quarter 2024 results: EPS: د.أ0.047 (down from د.أ0.11 in 2Q 2023). Revenue: د.أ2.16m (down 13% from 2Q 2023). Net income: د.أ329.8k (down 56% from 2Q 2023). Profit margin: 15% (down from 30% in 2Q 2023). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Board Change • Aug 29No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. No independent directors (9 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Oct 17No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Sep 13No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Jul 17No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • May 24No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Apr 11No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Mar 24No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Dec 17No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Nov 28No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Oct 19No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Sep 05No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Aug 15No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 7 experienced directors. No highly experienced directors. No independent directors (8 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Jun 16No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 7 experienced directors. No highly experienced directors. No independent directors (8 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • May 05No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 7 experienced directors. No highly experienced directors. No independent directors (8 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Apr 04No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 7 experienced directors. No highly experienced directors. No independent directors (8 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Mar 03No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 7 experienced directors. No highly experienced directors. No independent directors (8 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Nov 10No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. No independent directors (8 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Sep 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. No independent directors (8 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Sep 01No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. No independent directors (8 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Beit Jala Pharmaceutical は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測PLSE:BJP - アナリストの将来予測と過去の財務データ ( )JOD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/202513304N/A9/30/202512325N/A6/30/202512314N/A3/31/202511222N/A12/31/202410201N/A9/30/202491-10N/A6/30/20249102N/A3/31/20249212N/A12/31/202310212N/A9/30/202310222N/A6/30/202310233N/A3/31/202311222N/A12/31/202211233N/A9/30/202211233N/A6/30/202211211N/A3/31/202210112N/A12/31/202110101N/A9/30/20219102N/A6/30/20219102N/A3/31/20219112N/A12/31/20209102N/A9/30/20209101N/A6/30/20209112N/A3/31/20209202N/A12/31/20199101N/A9/30/201981N/A1N/A6/30/201981N/A0N/A3/31/201971N/A0N/A12/31/201871N/A1N/A9/30/201881N/A2N/A6/30/201881N/A2N/A3/31/201882N/A3N/A12/31/201782N/A3N/A9/30/201782N/A3N/A6/30/201782N/A3N/A3/31/201782N/A2N/A12/31/201682N/A3N/A9/30/201682N/A4N/A6/30/201682N/A3N/A3/31/201681N/A3N/A12/31/201582N/A3N/A9/30/201571N/A2N/A6/30/201561N/A1N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: BJPの予測収益成長が 貯蓄率 ( 15.1% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: BJPの収益がPS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: BJPの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: BJPの収益がPS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: BJPの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: BJPの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/04/12 03:51終値2026/01/13 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Beit Jala Pharmaceutical Company 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jul 16Beit Jala Pharmaceutical Company to Report First Half, 2026 Results on Jul 29, 2026Beit Jala Pharmaceutical Company announced that they will report first half, 2026 results on Jul 29, 2026
お知らせ • May 03Beit Jala Pharmaceutical Company Announces Distribution of Cash DividendsBeit Jala Pharmaceutical Company at the ordinary General Assembly, held on April 30, 2026, announced the distribution of cash dividends of 15% of the nominal value of the share.
お知らせ • Apr 10Beit Jala Pharmaceutical Company, Annual General Meeting, Apr 30, 2026Beit Jala Pharmaceutical Company, Annual General Meeting, Apr 30, 2026. Location: nablus Palestinian Authority
お知らせ • Mar 30+ 1 more updateBeit Jala Pharmaceutical Company to Report Second Half, 2025 Results on Apr 07, 2026Beit Jala Pharmaceutical Company announced that they will report second half, 2025 results on Apr 07, 2026
お知らせ • Dec 10Beit Jala Pharmaceutical Company to Report Nine Months, 2025 Results on Dec 18, 2025Beit Jala Pharmaceutical Company announced that they will report nine months, 2025 results on Dec 18, 2025
お知らせ • May 03Beit Jala Pharmaceutical Company announces Annual dividend, payable on June 30, 2025Beit Jala Pharmaceutical Company announced Annual dividend of JOD 0.1200 per share payable on June 30, 2025, ex-date on May 04, 2025 and record date on May 05, 2025.
お知らせ • Apr 11Beit Jala Pharmaceutical Company, Annual General Meeting, Apr 30, 2025Beit Jala Pharmaceutical Company, Annual General Meeting, Apr 30, 2025. Location: ramallah Palestinian Authority
Board Change • Oct 03No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. No independent directors (9 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • Sep 03Second quarter 2024 earnings released: EPS: د.أ0.047 (vs د.أ0.11 in 2Q 2023)Second quarter 2024 results: EPS: د.أ0.047 (down from د.أ0.11 in 2Q 2023). Revenue: د.أ2.16m (down 13% from 2Q 2023). Net income: د.أ329.8k (down 56% from 2Q 2023). Profit margin: 15% (down from 30% in 2Q 2023). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Board Change • Aug 29No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. No independent directors (9 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Oct 17No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Sep 13No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Jul 17No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • May 24No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Apr 11No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Mar 24No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Dec 17No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Nov 28No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Oct 19No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Sep 05No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Aug 15No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 7 experienced directors. No highly experienced directors. No independent directors (8 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Jun 16No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 7 experienced directors. No highly experienced directors. No independent directors (8 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • May 05No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 7 experienced directors. No highly experienced directors. No independent directors (8 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Apr 04No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 7 experienced directors. No highly experienced directors. No independent directors (8 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Mar 03No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 7 experienced directors. No highly experienced directors. No independent directors (8 non-independent directors). Director Rami Khlef was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Nov 10No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. No independent directors (8 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Sep 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. No independent directors (8 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Sep 01No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. No independent directors (8 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.